These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27663070)

  • 1. Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial.
    Knickelbein JE; Tucker WR; Bhatt N; Armbrust K; Valent D; Obiyor D; Nussenblatt RB; Sen HN
    Am J Ophthalmol; 2016 Dec; 172():104-110. PubMed ID: 27663070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subconjunctival sirolimus in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I/II clinical trial.
    Bhatt N; Dalal M; Tucker W; Obiyor D; Nussenblatt R; Sen HN
    Am J Ophthalmol; 2015 Mar; 159(3):601-6. PubMed ID: 25526946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis.
    Sohn EH; Wang R; Read R; Roufas A; Teo L; Moorthy R; Albini T; Vasconcelos-Santos DV; Dustin LD; Zamir E; Chee SP; McCluskey P; Smith R; Rao N
    Ophthalmology; 2011 Oct; 118(10):1932-7. PubMed ID: 21708408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab for the treatment of active scleritis.
    Sen HN; Sangave A; Hammel K; Levy-Clarke G; Nussenblatt RB
    Can J Ophthalmol; 2009 Jun; 44(3):e9-e12. PubMed ID: 19506593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.
    Suhler EB; Lim LL; Beardsley RM; Giles TR; Pasadhika S; Lee ST; de Saint Sardos A; Butler NJ; Smith JR; Rosenbaum JT
    Ophthalmology; 2014 Oct; 121(10):1885-91. PubMed ID: 24953794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
    Nussenblatt RB; Peterson JS; Foster CS; Rao NA; See RF; Letko E; Buggage RR
    Ophthalmology; 2005 May; 112(5):764-70. PubMed ID: 15878055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study.
    Tugal-Tutkun I; Kadayifcilar S; Khairallah M; Lee SC; Ozdal P; Özyazgan Y; Song JH; Yu HG; Lehner V; de Cordoue A; Bernard O; Gül A
    Ocul Immunol Inflamm; 2017 Feb; 25(1):62-70. PubMed ID: 26829647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.
    Ragam A; Kolomeyer AM; Fang C; Xu Y; Chu DS
    Ocul Immunol Inflamm; 2014 Dec; 22(6):469-77. PubMed ID: 24354512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis.
    Zamir E; Read RW; Smith RE; Wang RC; Rao NA
    Ophthalmology; 2002 Apr; 109(4):798-805; discussion 805-7. PubMed ID: 11927443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleritis therapy.
    Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
    Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse anterior scleritis and secondary glaucoma as a manifestation of adult T-cell prolymphocytic leukemia.
    Kommaraju KR; Moroi S; Demirci H
    Cornea; 2014 Aug; 33(8):873-4. PubMed ID: 24977988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis.
    Albini TA; Zamir E; Read RW; Smith RE; See RF; Rao NA
    Ophthalmology; 2005 Oct; 112(10):1814-20. PubMed ID: 16199269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate for the treatment of noninfectious scleritis.
    Sands DS; Chan SCY; Gottlieb CC
    Can J Ophthalmol; 2018 Aug; 53(4):349-353. PubMed ID: 30119788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.
    Silpa-Archa S; Oray M; Preble JM; Foster CS
    Acta Ophthalmol; 2016 Sep; 94(6):e400-6. PubMed ID: 27010181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Gevokizumab in Patients with Behçet's Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study.
    Tugal-Tutkun I; Pavesio C; De Cordoue A; Bernard-Poenaru O; Gül A
    Ocul Immunol Inflamm; 2018; 26(7):1023-1033. PubMed ID: 29370572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab therapy for refractory uveitis: a pilot study.
    Diaz-Llopis M; García-Delpech S; Salom D; Udaondo P; Hernández-Garfella M; Bosch-Morell F; Quijada A; Romero FJ
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):351-61. PubMed ID: 18476805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience With 0.1% Tacrolimus Eye Drop for Noninfectious, Non-necrotizing Anterior Scleritis.
    Yazu H; Miyazaki D; Fujishima H
    Eye Contact Lens; 2021 Apr; 47(4):185-190. PubMed ID: 32404650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of idiopathic necrotizing scleritis with secondary glaucoma treated successfully with golimumab and Ahmed valve implantation.
    Dutta Majumder P; ; David RL; Kaushik V
    Indian J Ophthalmol; 2019 Aug; 67(8):1360-1362. PubMed ID: 31332143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of Scleritis in an Egyptian Cohort.
    Abd El Latif E; Seleet MM; El Hennawi H; Abdulbadiea Rashed M; Elbarbary H; Sabry K; Abdelmonagy Ibrahim M
    Ocul Immunol Inflamm; 2019; 27(6):890-896. PubMed ID: 30412434
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphological features in anterior scleral inflammation using swept-source optical coherence tomography with multiple B-scan averaging.
    Kuroda Y; Uji A; Morooka S; Nishijima K; Yoshimura N
    Br J Ophthalmol; 2017 Apr; 101(4):411-417. PubMed ID: 27388252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.